SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-008310
Filing Date
2021-06-15
Accepted
2021-06-15 16:05:48
Documents
4
Period of Report
2021-07-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210709xdef14a.htm DEF 14A 391036
2 GRAPHIC tmb-20210709xdef14a011.jpg GRAPHIC 78024
3 GRAPHIC tmb-20210709xdef14a012.jpg GRAPHIC 76306
4 GRAPHIC tmb-20210709xdef14a001.jpg GRAPHIC 8319
  Complete submission text file 0001558370-21-008310.txt   616540
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37809 | Film No.: 211018528
SIC: 2834 Pharmaceutical Preparations